Application of terlipressin in the treatment of esophagogastric variceal bleeding in liver cirrhosis / 临床肝胆病杂志
Journal of Clinical Hepatology
;
(12): 2308-2311, 2019.
Article
in Chinese
| WPRIM
| ID: wpr-778739
ABSTRACT
Esophagogastric variceal bleeding (EVB) is a common fatal complication secondary to cirrhotic portal hypertension. Terlipressin can shrink visceral blood vessels, reduce portal pressure, and increase renal perfusion and is mainly used in the treatment of EVB. This article summarizes the mechanism of action and clinical effect of terlipressin in the treatment of EVB in liver cirrhosis and points out that if conditions permit, terlipressin combined with endoscopic variceal ligation should be the preferred treatment method for EVB.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of Clinical Hepatology
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS